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ABSTRACT

THE ROLE OF PAX3 IN NEURONAL DIFFERENTIATION OF THE
OPHTHALMIC (OPV) TRIGEMINAL PLACODE AND NEURAL
TUBE DURING CHICKEN EMBRYONIC DEVELOPMENT

James R. Bradshaw
Department of Zoology
Doctor of Science

Pax3 has been used as a valuable marker in research aimed at understanding
tissue interactions involved in trigeminal ophthalmic (opV) placode development. While
Pax3 expression coincides with opV neuron specification, the function of Pax3 in these
cells has not previously been investigated. Splotch mutant mice (which lack Pax3) have
a reduced trigeminal ganglion; however it is not clear whether this reduction is due to
neural crest or placode cells. We have used electroporation in the chick model system to
block or ectopically express Pax3 at key times in opV placode development. Using
several markers of placode cell differentiation, we have determined the experimental
effects manipulating Pax3. Blocking placodal Pax3 with gene specific morpholinos
resulted in a loss of migratory placode cells, and a downregulation of all opV placode

markers in targeted cells. Ectopic expression of Pax3, either within the placode domain
or in adjacent cranial ectoderm, resulted in the upregulation of some but not all placode
markers. We conclude that opV placodal Pax3 expression is required for normal placode
cell development, and hypothesize that its expression must be tightly regulated in order
for placode cells to fully differentiate.
The precise role of Pax3 and Pax7 in the restriction and differentiation of dorsal
interneuron progenitors has been difficult to assess due to the many additional factors
involved in specification and patterning of the neural tube. We have used electroporation
in the chick model system to ectopically express Pax3 and Pax7 unilaterally in the neural
tube. Using several markers for differentiation of ventral and dorsal neuronal
progenitors, we have experimentally determined the effects of Pax3 and Pax7 ventrally
and dorsally. Ectopic expression of these transcription factors in the ventral neural tube
resulted in the loss of motorneurons. Though mis-expression did not qualitatively affect
commissural neurons as assayed by neurofilament staining, ectopic expression of Pax3
and Pax7 in the dorsal neural tube stopped dorsal interneuron progenitors from
differentiating. We conclude that Pax3 and Pax7 expression is sufficient to restrict
ventral neuron identity. We also hypothesize that downregulation of these transcription
factors in the dorsal neural tube is required for normal dorsal interneuron differentiation.
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Chapter 1
Introduction
During embryonic neuronal development in vertebrates, fields of ectoderm
undergo dramatic changes, giving rise to the various components that comprise the adult
nervous system. The complex spatiotemporal patterns of gene expression and the many
cell fate decisions that are made throughout the nervous system provide ample challenges
to neuroscientists studying embryonic development. One model of neurogenesis, the
cranial placodes, has been studied more extensively in recent years. Cells within the
cranial placodes become specified as sensory neuron precursors, delaminate and
differentiate as sensory neurons within the ganglia of cranial nerves V, VII, VIII, IX and
X (reviewed in Baker and Bronner-Fraser, 2001). The ophthalmic trigeminal (opV)
placode is an excellent model for studying neurogenesis as this neurogenic field has been
well described, particularly in the chick embryo model system. In addition, the opV
placode is a somewhat simpler model to study than other placodes, such as the otic, in
that cells only contribute to sensory neurons of the ophthalmic trigeminal ganglion
(D’Amico-Martel and Noden, 1983).
As trigeminal placode cells differentiate, they undergo an epithelial to
mesenchymal transition (EMT), and migrate toward the site of ganglion condensation
where they group together with neural crest-derived neurons and glia (Hamburger, 1961;
D’Amico-Martel and Noden, 1983). It has been shown that neural crest cells are not
required for placode formation (Stark et al., 1997) or for gangliogenesis and cellular
differentiation by placode-derived neurons (Hamburger, 1961). However, trigeminal
neural crest cells likely act as an important aggregation center for placode-derived
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neurons (Hamburger, 1961), for without the neural crest, the ganglion is abnormally
shaped and positioned.
Various molecular markers of placodal neurogenesis have been identified and
used to study the key developmental events. Two of the earliest known markers
expressed in the opV placode are the paired homeobox domain transcription factor Pax3,
and the fibroblast growth factor receptor 4 (FGFR4) (Stark et al., 1997; Sommer et al.,
1996). Since Pax3 has been identified as the earliest known marker of the opV placode,
several studies have utilized Pax3 as a key cellular marker. Though it is unclear whether
Pax3 is responsible for the specification and commitment of placode cells to become opV
placode-specific sensory neurons, it has been shown that Pax3 expression in opV placode
cells corresponds to their commitment to a cutaneous sensory neuronal cell fate (Baker et
al., 1999; Baker and Bronner-Fraser, 2000; Baker et al., 2002).
During opV placode formation, competent cranial ectoderm cells are induced to
express Pax3 by a signal from the dorsal neural tube that is present along the entire
antero-posterior neuraxis (Stark et al., 1997; Baker et al., 1999). Spatiotemporal changes
in competence to respond to the Pax3-inducing signal seem to contribute to restriction of
Pax3 induction to the opV placode. For example, prospective otic placodal ectoderm
loses competence to respond to the signal after the 3-somite stage, while trunk ectoderm
is never competent (Baker et al., 1999). While extensive work has gone toward
understanding tissue interactions that lead to placode induction, and the cellular potential
of opV placode cells, little is known concerning the function of the various genes
expressed in the placode.
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Pax3 is expressed in opV placode cells as they delaminate from the surface
ectoderm (undergo EMT), move into the cranial mesenchyme, and aggregate together
with neural crest cells to form the trigeminal ganglion. FGFR4 expression in the
trigeminal placode occurs just prior to EMT and is preceded by high levels of Pax3
expression (Stark et al., 1997). By the 10-somite stage (10-ss), FGFR4 expression is
detectable in a subset of Pax3 expressing opV placode cells (Stark et al., 1997). It
appears from detailed expression studies that as the cells enter the underlying
mesenchyme, FGFR4 is quickly downregulated, while Pax3 expression is maintained
through late gangliogenesis (Stark et al. 1997). The function of FGFR4 is still unknown
and is currently being investigated. Neurogenin-2 (Ngn2) and Brn-3a are also expressed
in chick opV placode cells concomitantly with FGFR4 (Begbie et al., 2002). In the
chick, Ngn2 is specific to the opV placode and is not expressed in any other placodes
during development (Begbie et al., 2002). Studies involving targeted inactivation of
Neurogenins show they are required early in the generation of different subsets of cranial
and trunk sensory neurons, and that a null mutation for Ngn2 blocks the EMT of neuronal
precursors from the placodal ectoderm (Fode et al., 1998; Ma et al., 1998). While Brn-3a
is expressed in all cranial neurogenic placodes, it is expressed earlier in opV placode cells
compared to other neurogenic placodes (Begbie et. al. 2002). Brn-3a is necessary for the
proper development and/or survival of neurons in the sensory ganglia as shown by
targeted mutations in mice (McEvilly et al., 1996; Xiang et al., 1996).
While the role of Pax3 in opV placode development has not been specifically
investigated, there are some hints as to its function. Antisense oligonucleotide downregulation of Pax3 in neural crest cultures inhibited sensory neuron differentiation
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without affecting survival of sensory neurons or precursor populations (Koblar et al.,
1999). Microinjection with Pax3 expression vectors in Schwann cell cultures elevated
genes specific to myelinating Schwann cells, suggesting a role for Pax3 in the
differentiation of these cells (Kioussi et al., 1995). Pax3-deficient Splotch mice exhibit
several developmental defects, including muscle, trunk neural crest and neural tube
defects. The Splotch mutation results in a migration failure of limb muscle precursors
(Daston et al., 1996). Neural crest related defects may be due to the influence of Pax3
on neural crest precursor survival, cell migration, proliferation, and/or differentiation
(Conway et al., 2000; Epstein et al., 2000). Splotch mice also show a reduction in the
opV nerve (Tremblay et al., 1995), hinting at the possibility that opV placode cells are
affected (Stark et al., 1997). However, several possibilities exist to explain the opV nerve
reduction in Pax3 deficient mice. The three principal tissues involved in the formation
of the opV nerve express Pax3: the neural crest and placode cells contribute to the
trigeminal ganglion, and the neural tube is involved in opV placode induction. The opV
ganglion defects observed in the mutants could therefore be the result of a defect in the
contributing neural crest cells, a defect in the placode-inducing tissue (the dorsal neural
tube), or an intrinsic placode cell defect. To distinguish between these possibilities and
to investigate the placode-intrinsic function of Pax3, we have used electroporation
techniques to introduce Pax3-specific morpholinos to knockdown endogenous Pax3
protein. We have also ectopically expressed Pax3 within the opV placode and in other
regions of cranial and trunk ectoderm at key developmental stages. We show that Pax3 is
necessary for normal opV placode development, and that Pax3 is sufficient to upregulate
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Figure 1. Gene expression in the OpV placode.
The diagram of chicken embryo development shows where the different cranial placodes
will form. Although other areas of development express Pax3, FGFR4, and Ngn2, in situ
hybridizations show that within the cranial placodes, expression of these genes are
restricted to the OpV placode during development.
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some downstream opV placode-specific cell markers, but that in general it is not
sufficient to promote full neuronal differentiation.

Materials and Methods
Production of Pax3, Pax7, and Control Mis-expression Vectors
A pCL-GFP vector, obtained from Dr Christophe Marcelle (Developmental
Biology Institute, Marseille), contains a polylinker flanked by a CMV promoter, and a
separate region containing the SV40 promoter driving Green Fluorescent Protein (GFP)
(Scaal et. al. 2004). For our experiments, this vector was modified by replacing the CMV
promoter and the associated intron sequence with the RSV promoter sequence from
pRc/RSV (Invitrogen). This modified vector (named Cont/GFP) was used for
electroporation controls. Full length chicken Pax3 cDNA, obtained from Eiji Matsunaga
(Matsunaga et. al. 2001), was inserted into the modified vector (named Pax3/GFP).
Because of proposed functional redundancy between Pax3 and Pax7 in tissues where they
are co-expressed such as muscle precursors (Relaix et al., 2005) and the neural tube
(Mansouri et al., 1998), Pax7 was used to test whether Pax3 and Pax7 had similar
properties when ectopically expressed in surface ectoderm. The Pax7 mis-expression
vector (named Pax7/GFP) used for controls was kindly provided by Laura Burrus (San
Francisco State University).

Antisense Morpholino Oligonucletides
Fluorescein tagged morpholinos were obtained from Gene Tools, LLC. GenBank
Accession number AB080581 for the Gallus gallus mRNA paired-box transcription
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factor protein Pax-3 was submitted to Gene Tools and a custom antisense oligonucleotide
sequence (5'-CCAGCGTGGTCATCGCGGCGGCGC-3') was designed to bind to the 5'
UTR sequence including the initiation methionine. A mismatched Pax3 control
morpholino (5'-CCACCGTCGTCATCCCGGAGGAGC-3') and standard control
morpholino (5'-CCTCTTACCTCAGTTACAATTTATA-3') were used in control
embryos. Pax3 and standard control morpholinos were resuspended in nanopure water
[10 µg/µl] and stored at -80ºC in 10 µl aliquots until use. Morpholinos were diluted 1:2
in 15% sucrose/fast green solution in preparation for in ovo electroporation.
Morpholinos were also tagged with fluorescein for visual confirmation of targeting.

In Ovo Electroporations
Fertilized chicken eggs from Utah State University were incubated in a
humidified atmosphere at 37.5ºC. Pax3, Pax7, or control electroporation vectors (5.0
µg/µl), and Pax-3 morpholinos or standard control morpholinos (5.0 µg/µl) were
introduced into target tissues by in ovo electroporation as described by Van Raay and
Stark (2002). Eggs were windowed using standard techniques in preparation for
electroporations. PBS/0.5% Penn-strep was used to keep the area around the embryo
from drying and to reduce the chance of bacterial growth during development after
manipulation. Briefly, electrodes were placed on opposing sides of the embryo. Vector
DNA was injected adjacent to target tissue and a current was applied using a square pulse
electroporator (BTX). The following parameters were used for all electroporations: 5
pulses, 12V, 10msec/pulse. After the target tissue was electroporated, the embryo was
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Figure 2. Mis-expression vectors used for electroporations.
Originally two plasmid constructs were designed for electroporations. The RSV vector
produced more robust expression after electroporations, and so it was used for these
experiments. In the RSV vector, the process of inserting the new promoter removed the
intron sequence adjacent to the MCS, which may account for differences in expression.

Figure 3. Knockdown of genes through morpholinos.
Morpholinos work differently than siRNA which has been the more conventional way of
knocking down gene expression in the past. Instead of binding to the RNA and causing
degradation of the mRNA, the morpholinos bind to a 5’UTR sequence and halt
progression of the initiation complex, thereby preventing transcription. The morpholinos
are resistant to nucleases and remain stable in cells for longer periods of time than
siRNA.
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Figure 4. In Ovo Electroporation.
Electroporations can target various tissues as shown above. Targeting of ectoderm or
neural tube can be accomplished with correct placement of the electrodes and the vector.
(A) Fluorescein tagged morpholino electroporated into opV placode before incubation.
(B) Electroporated ectoderm 24 hours after incubation. (C) Electroporated neural tube 24
hours after incubation.
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again washed in PBS/Penn-strep, the egg shell was sealed with transparent tape, and the
egg was placed in the incubator to continue development.

Cloning of chick FGFR4 and Ngn2 Probes
In order to isolate a chicken FGFR4 (FREK) gene fragment useful for an in situ
hybridization probe, we first PCR-amplified a 400bp fragment from a cDNA library of
homogenized 3-10 somite stage (ss) chick embryos using primers with the following
sequences: 5'-GGAGATGGAGCCAGACTCG-3' and (degenerate)
5'-ACCTCTCCAGCACRTCCA-3'. The PCR product was cloned into the pGEM-T easy
vector (Promega). The clone was sequenced at the BYU DNA Sequencing Center, and a
comparison of sequences showed that the 400bp fragment matched a region of cFrek
mRNA (GenBank accession number AF083063) from 54bp to 454bp. The Ngn2 probe
used was generated from PCR amplification of a cDNA library of homogenized 3-10ss
chick embryos with the following primer sequences: 5'-TGGGTTTTCAGTCCGTTGAT3' and 5'-CCCTACGCCTGCACTTTATC-3'. The primers were designed to amplify a
500 bp fragment specific to the Gallus gallus neurogenin2 (GenBank accession number
AJ012659). The PCR product was cloned into the pGEM-T easy vector (Promega). The
sequence was confirmed, and a 100 bp long fragment corresponding to base pair 228-326
was used to generate a gene-specific in situ hybridization probe.

In Situ Hybridization
FGFR4 and Ngn2 digoxigenin-labeled RNA probes were synthesized and used
for whole-mount in situ hybridization on formaldehyde fixed chick embryos as described
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by Wilkinson (1992) and Henrique et al. (1995). After in situ hybridization, embryos
were formaldehyde fixed and photographed (see Figure 1). Most embryos were then
cryosectioned as previously described (Sechrist et al. 1995). Sections were mounted on
Superfrost® Plus glass slides (Fisher), and the gelatin was removed by treating the slides
in phosphate-buffered saline (PBS) at 37°C for 15 minutes. Immunohistochemical
staining was used for visualization and analysis of additional opV placode markers.

Immunohistochemistry
Embryos were collected after 8 to 48 hours of incubation post-electroporation,
fixed in 4% formaldehyde for 1 hour at room temperature and processed for cryostat
sectioning as described by Sechrist et al. (1995). Sections 12-16 µm thick were mounted
on Superfrost® Plus glass slides (Fisher) and the gelatin removed by treating the slides in
phosphate-buffered saline (PBS) at 37°C for 15 minutes. Slides were incubated
overnight at 4°C in primary antibody solution, and 1 hour in secondary antibody solution
at room temperature, with three 5-minute washes after incubation with each antibody
solution. Coverglasses were mounted using Fluoromount-G (Southern Biotechnology
Associates, Inc.) and sections were viewed by fluorescent and/or confocal microscopy.
Antibodies (See Table 1) were diluted in antibody buffer consisting of 0.1% BSA and
0.1% Triton in PBS. Table 1 lists the primary antibodies used in this study, the dilutions
used, their sources, and appropriate references. Subtype-specific Alexa350-, Alexa488-,
Alexa546-, and Alexa633-conjugated secondary antibodies were obtained from
Molecular Probes and used as secondary antibodies.
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Analysis of OpV Placode Cell Counts
Individual cell counts within the opV placode were necessary to analyze statistical
significance between experimental and control embryos. To quantitatively compare
electroporated versus contralateral opV placode cells, select embryos were photographed
and cells expressing the marker of interest were counted on both the electroporated and
the contralateral sides through the entire opV placode region. For each embryo, the cell
counts were expressed as a ratio of the total number of cells expressing a marker of
interest on the electroporated side, divided by the total number of contralateral (control)
cells expressing the marker of interest. By averaging the mean ratios of all embryos
counted in each experimental group, the average and standard deviation were calculated.
A t-test was used to compare the average and standard deviation of experimental embryos
to control embryos. Averages and standard deviations from wildtype mean ratios were
calculated and compared to experimental embryos to test for statistical significance.
Values reported are in the format (average ratio ± standard deviation).
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Results
Knockdown of Pax3 results in loss of opV placode markers
In normal chick embryos, Pax3, the earliest known marker specific for the opV
placode, is expressed in the midbrain neural folds and adjacent ectoderm as early as the
3ss. The ectodermal expression domain translocates laterally and becomes refined to the
presumptive opV placode by the 9-12ss. By the 10ss, FGFR4 and Ngn2 are expressed in
a subset of Pax3 expressing placode cells (Stark et al. 1997; Begbie et al. 2002).
Placode-derived neuronal precursors subsequently delaminate, begin to downregulate
FGFR4 and Ngn2, and migrate toward the condensing ganglion. Markers that can be
detected in these migratory cells include Pax3, Brn-3a, and the post-mitotic marker Islet1.
To determine whether Pax3 expression in the opV placode is required for sensory neuron
development, we introduced Pax3 morpholinos (p3MO) into placodal and surrounding
ectoderm at the 3-10 somite stage (ss) by electroporation (Fig.5B). Similar experiments
using standard control morpholinos (cMO) (Fig.5A) and mismatched Pax3 morpholinos
(mMO) were performed as controls. Embryos electroporated with cMO, mMO, and
p3MO were collected 24 hours after experimentation, and prepared for in situ
hybridization and immunohistochemistry as described. In situ analysis of embryos
electroporated with cMO (Fig.6A, C) or mMO (Fig.6B, D) showed no apparent reduction
in opV placodal FGFR4 or Ngn2 expression. Wholemount in situ analysis of p3MO
embryos revealed a marked reduction or loss of FGFR4 (n=14) and Ngn2 (n=7) when
compared with the contralateral opV placode (Fig.6C, F), and compared with control
embryos. To confirm reduction or loss of Pax3 protein, immunohistochemistry
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Figure 5. Chick embryos electroporated with p3MO. (A-B) Immediately after
electroporation with cMO (A) and p3MO (B), fluorescein labeled morpholino is visible in
targeted ectoderm. Some residual morpholino typically pooled lateral to the head, but
never cellularized as assayed in sections. (C-D) Immunohistochemistry on sections
through the opV placode reveals Pax3-specific knockdown after p3MO electroporation.
(C, C’) Control embryo after cMO electroporation. (C’) Enlargement of box in (C),
shows several targeted cells expressing Pax3, indicating that cMO does not affect normal
Pax3 expression (C’, arrow). (D, D’) After p3MO electroporation, fewer Pax3+ cells are
visible in the targeted opV placode than in the contralateral opV placode (D, arrow).
(D’) Enlargement of box in (D) shows a few untargeted Pax3+ cells in the mesenchyme
(arrow), but targeted cells were not seen expressing Pax3 protein (D’, arrowhead).
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Figure 6. FGFR4 and Ngn2 expression in the OpV placode (A-F) Whole-mount in
situ hybridization for FGFR4 and Ngn2 in cMO electroporated embryos (A, D), mMO
electroporated embryos (B, E), and p3MO electroporated embryos (C, F). In p3MO
electroporated embryos, FGFR4 (C, arrow) and Ngn2 (F, arrow) were consistently
downregulated on the targeted side.
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was performed to detect Pax3 protein. Fluorescent microscopy revealed that cells
targeted with p3MO (detectable by fluorescently labeled morpholino) lacked detectable
Pax3 protein (Fig.5C, C’), confirming cell-autonomous loss of Pax3 targeted cells. This
was not the case with cMO, where Pax3 protein was frequently present in targeted cells
(Fig.5D, D’). Qualitative analysis of mMO electroporated embryos revealed that Pax3
levels were not affected (data not shown), further indicating the specificity of the Pax3
morpholino. As an additional test for specificity of Pax3 knockdown, p3MO was also
electroporated into the dorsal neural tube. Through double staining of Pax3 and Pax7, it
was shown that Pax3 was knocked down while Pax7 expression remained normal (data
not shown). Though Pax3 and Pax7 share a similar function and sequence homology,
p3MO was shown to be specific to knocking down Pax3.
Immunohistochemical analysis allowed detection of other opV placode markers
such as Brn-3a, and Islet1. Since Brn-3a is expressed in the opV placode and has been
shown to be necessary for cranial sensory neuron development (McEvilly et al., 1996;
Xiang et al., 1996), we used it as one of the genetic markers of opV placode
differentiation. Within the cranial sensory placodes, only the opV placode generates
sensory neurons that are post-mitotic during migration and early ganglion condensation
(Begbie et al. 2002). Islet1 is expressed in these post-mitotic migratory opV placode
cells and was therefore used as another marker. Wildtype (WT) embryos showed no
difference between the left and right opV placodes in the number of Brn-3a+ and Islet1+
cells (Fig.7A, D). Embryos electroporated with cMO also showed equal levels of Brn3a+ and Islet1+ cells between left and right opV placodes (Fig.7B, E). Loss of Pax3
protein in embryos electroporated with p3MO was also coupled with a loss in Brn-3a+
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cells (Fig.7C) and Islet1+ cells (Fig.7F). Variability in targeting occasionally resulted in
some ectodermal Pax3 positive cells being identified (Fig.7F). Other markers such as
Ngn2 were noticeably reduced (Fig.7I) when compared to WT (Fig.7G) and cMO
(Fig.7H) embryo sections. Because of this variability, which we attributed primarily to
timing of experimentation and targeting success, and because detection of the fluorescent
morpholino tag was often unreliable after in situ hybridization and/or
immunohistochemical preparation, we concluded that the best approach to quantify the
effects of blocking Pax3 on downstream placodal markers was to compare the
experimental placode with the contralateral placode, and report the ratio of cells
expressing a given marker (Fig.8). WT averages for Pax3+ cells (0.973 ± 0.080), Brn3a+ cells (1.013 ± 0.090), and Islet1+ cells (0.919 ± 0.200) showed relatively equal cell
ratios between the targeted and contralateral opV placode regions. Embryos
electroporated with cMO (n=12) were stained and analyzed, revealing that the averages
were not significantly different from WT opV placode cell ratios in Pax3+ cells (0.980 ±
0.167), Brn-3a+ cells (0.889 ± 0.157), and Islet1+ cells (1.028 ± 0.270). In embryos
electroporated with p3MO (n=13), the opV placode cell ratios for Pax3+ cells (0.328 ±
0.122), Brn-3a+ cells (0.298 ± 0.112), and Islet1+ cells (0.322 ± 0.182) were significantly
different from the control (cMO) electroporated and WT ratios (p<0.05) for all markers.
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Figure 7. Cross-section analysis of morpholino knockdown. Immunohistochemistry
on transverse sections through the opV placode show downregulation of various opV
placode markers in response to p3MO electroporation. In all panels, left is the control
side, and right is the electroporated side of the embryo. (A-F) Immunofluorescence
staining of WT, cMO, and p3MO cross sections showing expression of Pax3 (red), Brn3a (green in A-C), and Islet1 (green in D-F) in the opV placode. WT (A, D) and cMO (B,
E) sections show several Pax3+ cells co-expressing Brn-3a or Islet1. In p3MO
sections(C, F), however, Pax3+ cells co-expressing Brn-3a (C), or Islet1 (F) are not
detected in the mesenchyme when compared to contralateral opV placode cells (arrows).
(G-I) Brightfield of sections D-F showing Ngn2 expression in the opV placode.
Downregulation of Ngn2 in the opV placode is apparent in p3MO (I, arrowhead),
whereas Ngn2 expression in WT (G) and cMO (H) remains unchanged. A few Pax3+
cells are occasionally detected in the ectoderm (F, arrowhead), but are void of Ngn2
expression (I, arrowhead).
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Figure 8. Graph showing the averaged right:left ratios of Pax3+ or Islet1+ cells in the
WT opV placode, and the averaged experimental:contralateral ratios of Pax3+ or Islet1+
cells in cMO electroporated and p3MO electroporated embryos. The resulting p3MO
ratios were significantly different from WT and cMO ratios (*P<0.05). Paired t-test was
used to generate statistical significance.
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Table 1. Summary of morpholino experiment results
p3MO Electroporations

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
14
14

Number with normal
expresion in OpV
placode (%)
4 (29)
5 (36)

Number with reduced
expresion in OpV placode
(%)
10 (71)
9 (64)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
13
10
13

Average OpV
placode cell counts
0.328
0.298
0.322

STDEV of OpV placode
cells counts
0.133
0.112
0.182

Gene Analyzed
(cMO) FGFR4
(cMO) Ngn2
(mMO) FGFR4
(mMO) Ngn2

Total
Number of
Embryos
9
8
10
9

Number with normal
expresion in OpV
placode (%)
9 (100)
8 (100)
10 (100)
9 (100)

Number with reduced
expresion in OpV placode
(%)
0 (0)
0 (0)
0 (0)
0 (0)

Gene Analyzed
(cMO) Pax3
(cMO) Brn-3a
(cMO) Islet1

Total
Number of
Embryos
Sectioned
6
6
6

Average OpV
placode
cell counts
0.98
1.028
0.889

STDEV of OpV placode
cells counts
0.167
0.27
0.157

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
5
5

Number with normal
expresion in OpV
placode (%)
5 (100)
5 (100)

Number with reduced
expresion in OpV placode
(%)
0 (0)
0 (0)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
5
5
5

Average OpV
placode
cell counts
0.973
1.013
0.919

STDEV of OpV placode
cells counts
0.08
0.09
0.2

Control Morpholino
Electroporations

WT Embryos
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Co-electroporation with Pax3/GFP and p3MO restores Pax3 protein, but does not
rescue expression of most downstream opV placode markers
Having demonstrated that knockdown of Pax3 using p3MO resulted in
downregulation of all tested opV placode markers (confirming the necessity of placodal
Pax3 in normal placode development), we aimed to determine whether we could rescue
expression of opV placode markers by concomitantly mis-expressing Pax3 with p3MO
knockdown. These experiments were originally designed to test the specificity of our
Pax3 morpholino. Embryos were electroporated simultaneously with Pax3/GFP and
p3MO between somite stages 3-10. Embryos were collected 24 hours after
experimentation, and prepared for in situ hybridization and/or immunohistochemistry to
detect Pax3, FGFR4, Ngn2, Brn-3a, and Islet1.
To test for restoration of Pax3 protein, sections through the targeted region, as
determined by GFP expression, were analyzed in control and experimental embryos. In
p3MO+Pax3/GFP experimental embryos, Pax3 protein expression in targeted cells was
restored to normal or above normal levels (Fig.9B) while in p3MO+Cont/GFP control
embryos, Pax3 protein remained undetectable (Fig.9A), similar to electroporation with
p3MO alone. This demonstrated the restoration of Pax3 protein in the presence of p3MO.
As a point of interest, most GFP-positive cells from p3MO+Pax3/GFP experimental
embryos were noticeably absent from the mesenchyme, being primarily located in the
ectoderm (Fig.9B). We next examined p3MO+Pax3/GFP experimental embryos for
changes in FGFR4 expression by in situ hybridization. 10 embryos showed expanded
FGFR4 expression in targeted cranial ectoderm (Fig.10A). In 4 of these embryos,
FGFR4 appeared partially reduced in the domain corresponding to the opV placode (as
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judged by contralateral FGFR4 expression), but showed an expansion in adjacent cranial
ectoderm. p3MO+Pax3/GFP experimental embryos were also examined by situ
hybridization for Ngn2 expression. Surprisingly Ngn2 expression was dramatically
reduced in the opV placode (Fig.10B), strikingly similar to what was observed in p3MO
experiments (Fig.5F). Cross sectional analysis of in situ embryos showed Pax3+ cells in
the targeted region (FGFR4, Fig.10C, E; Ngn2, Fig.10D, F). Finally we examined
changes in other markers by immunohistochemistry on serial sections. A marked
reduction in Brn-3a (Fig.9B) and Islet1 (Fig.10E) was also observed, with no apparent
restoration of these markers. Throughout these serial sections, it was especially striking
to observe a near lack of Pax3+ mesenchyme cells in contrast to the heavily populated
overlying ectoderm (Fig.9B).
To quantify differences between control and experimental embryos, we again
performed cell counts comparing the electroporated versus contralateral opV placode.
Because the targeting typically expanded beyond the normal opV placode domain, and
because most Brn-3a and Islet1 positive cells are normally found in the mesenchyme,
cells in the opV placodal ectoderm were not counted. Instead, only opV placode
mesenchyme cells expressing the marker of interest were counted (Fig.11). The average
cell ratios in p3MO+Pax3/GFP experimental embryos showed a drastic reduction in
mesenchymally located Pax3 positive cells (0.296 ± 0.149), Brn-3a positive cells (0.223
± 0.103), and Islet1 positive cells (0.263 ± 0.137) in the targeted side compared to the
contralateral side. All of the cell count ratios were significantly different from WT ratio
averages (p<0.05).
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Figure 9. Immunostained sections through the opV placode showing Pax3 (red) and
Brn-3a (blue) protein expression. Targeted tissue expresses GFP. (A) In control
experiments (p3MO + Cont/GFP), Pax3 is lost, and Brn-3a is downregulated similar to
that of embryos electroporated with p3MO alone. (B) Embryos electroporated with
p3MO + Pax3/GFP show restoration of Pax3 in targeted ectoderm (arrow), however Brn3a is not restored, and targeted cells do not undergo EMT as seen contralaterally (A-B,
arrowhead).

31

Figure 10. Restoration of Pax3 protein after co-electroporation with p3MO and
Pax3/GFP results in rescue of FGFR4 expression, but not other opV placode markers.
(A) Whole-mount FGFR4 in situ showing rescue of FGFR4 in the opV placode and
expansion of its expression in cranial ectoderm. (B-C) Cross section of FGFR4 in situ
embryo shows immunofluorescent staining of Pax3 (red) and Islet1 (green). Even though
Pax3 protein and FGFR4 mRNA are restored in targeted ectoderm (B-C, arrowheads),
migrating Pax3+ cells co-expressing Islet1 and FGFR4 are lost when compared to the
contralateral placode (B-C, arrows). (D) Whole-mount Ngn2 in situ showing loss of
expression in electroporated opV placode. (E-F) Cross section of Ngn2 embryo after in
situ hybridization for Ngn2 shows immunofluorescent staining of Pax3 (red) and Islet1
(green). Pax3 protein is restored in targeted ectoderm (E, arrowhead), Ngn2 is
downregulated (F, arrowhead), and Pax3+ cells co-expressing Islet1 are again lost from
the mesenchyme when compared to the contralateral opV placode (E-F, arrows).
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Figure 11. Graph showing the averaged right:left ratio of Pax3+, Islet1+ or Brn-3a cells
in the WT opV placode, and the averaged experimental:contralateral ratios of Pax3+,
Islet1+ or Brn3a cells in p3MO and p3MO + Pax3/GFP electroporated embryos. The
resulting experimental ratios were significantly different from WT and cMO (not shown)
ratios (*P<0.05). Paired t-test was used to generate statistical significance.
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Table 2. Summary of rescue experiment results
p3MO Electroporations

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
14
14

Number with normal
expresion in OpV
placode (%)
4 (29)
5 (36)

Number with reduced
expresion in OpV
placode (%)
10 (71)
9 (64)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
13
10
13

Average OpV
placode cell counts
0.328
0.298
0.322

STDEV of OpV
placode cells counts
0.133
0.112
0.182

p3MO Electroporations + Pax3 Mis-expression

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
11
10

Number with normal
expresion in OpV
placode (%)
7 (64)
0 (0)

Number with reduced
expresion in OpV
placode (%)
4 (36)
10 (100)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
6
5
6

Average
mesenchymal
counts
0.296
0.263
0.223

STDEV of
mesenchymal cells
counts
0.149
0.137
0.103

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
5
5

Number with normal
expresion in OpV
placode (%)
5 (100)
5 (100)

Number with reduced
expresion in OpV
placode (%)
0 (0)
0 (0)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
5
5
5

Average OpV
placode cell counts
0.973
1.013
0.919

STDEV of OpV
placode cells
counts
0.08
0.09
0.2

cell

WT Embryos
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Pax3 over-expression within the opV placode field leads to a significant reduction in
Brn3a- and Islet1-expressing cells
Brn-3a and Islet1 are normally expressed in opV placode cells by 10-12ss, 9-12
hours after initial opV placodal Pax3 expression. Surprisingly, initial experiments
revealed that over-expressing Pax3 by electroporating Pax3/GFP unilaterally into the
opV placode led to a reduction, rather than an increase, in the numbers of Brn-3a+ and
Islet1+ cells on the electroporated side. Since attempts to rescue the Pax3 morpholino
phenotype by over-expressing Pax3 in the opV placode also led to a dramatic reduction
of Brn3a+ and Islet1+ cells, we carefully examined this region in embryos collected 24
hours after electroporation with Cont/GFP, Pax7/GFP, and Pax3/GFP. The Cont/GFP
vector was used as a standard control, while Pax7/GFP was used to determine whether
Pax7 (not expressed endogenously in the opV placode) could substitute for Pax3 in
placode development. Over-expression of Pax3 in embryos electroporated with
Pax3/GFP showed strong upregulation of ectodermal Pax3 (as in the Pax3/GFP+p3MO
rescue experiments), but led to a reduction in Pax3+ cells in the mesenchyme (Fig.12C),
whereas Cont/GFP and Pax7/GFP electroporations showed no change in Pax3 protein
expression within the opV placode and adjacent mesenchyme (Fig.12A, B). While
Pax3+ and Brn-3a+ cells were not affected in Cont/GFP and Pax7/GFP electroporations
(Fig.12D, E), Pax3 over-expression led to a reduction in Brn-3a+ cells in the
mesenchyme when compared to the contralateral opV placode (Fig.12F). Similar to
rescue experiments, Pax3 over-expression in the opV placode resulted in loss of Ngn2
expression in electroporated ectoderm (Fig.12I). Cont/GFP and Pax7/GFP again
showed no change in Ngn2 expression in electroporated embryos (Fig.12G, H).
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Quantitative analysis was again necessary to test for statistical significance for
the apparent loss of Pax3+, Brn-3a+, and Islet1+ cells in Pax3/GFP electroporated
embryos. As in the rescue experiments, only cells in the mesenchyme were counted,
whereas cells in the surface ectoderm were excluded on both the electroporated and
contralateral sides (Fig.13). The cell ratios in embryos electroporated with Cont/GFP
showed no significant change in Pax3+ cells (0.967 ± 0.110), Brn-3a+ cells (1.118 ±
0.333), or Islet1+ cells (0.911 ± 0.067) when compared with WT control embryos. The
cell ratios for Pax7/GFP electroporations again showed no statistically significant
difference in Pax3+ cells (0.950 ± 0.102; p=0.84), Brn-3a+ cells (0.844 ± 0.063; p=0.41),
and Islet1+ cells (0.857 ± 0.202; p=0.36) compared to controls, although there does
appear to be a trend toward reduction. Conversely, Pax3/GFP electroporated embryo cell
ratios showed a significant reduction in Pax3+ cells (0.527 ± 0.198), Brn-3a+ cells (0.305
± 0.107), and Islet1+ cells (0.316 ± 0.210) found in the mesenchyme compared to
average Cont/GFP and Pax7/GFP ratios (p<0.05 for all cell count ratios).

Mis-expression of Pax3 outside the opV placode field will cause ectopic expression of
some opV placode markers
Here we used opV placode specific markers to determine whether ectodermal
Pax3 expression outside the opV placode domain is sufficient to cause cells to delaminate
and undergo opV placode-type neurogenesis. We ectopically expressed Pax3 by
electroporating Pax3/GFP into surface ectoderm from the mesencephalon to the third
somite in 3-10ss embryos, thereby targeting a broad region of cranial ectoderm, including
the presumptive opV placode and adjacent ectoderm that is competent to respond to the

40

Figure 12. Transverse sections through Cont/GFP, Pax7/GFP, and Pax3/GFP
electroporated embryos. In Cont/GFP and Pax7/GFP targeted embryos, Pax3 (red), Brn3a (blue) and Ngn2 expression appeared similar when comparing the electroporated and
contralateral sides of each embryo section, indicating opV placode development was not
affected. For example, in E, migratory Pax7+ cells (pseudocolored green) can be seen coexpressing endogenous Pax3+ and Brn-3a+ (arrow). Pax3/GFP electroporation resulted
in overexpression of ectodermal Pax3 protein (C, F arrowheads), but a reduction or loss
of migratory Pax3+, Brn-3a + and Ngn2 expressing cells when compared with normal,
contralateral expression (C, F, I arrows). Sections shown in G-I are brightfield images of
sections D-F.
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Figure 13. Graph showing the averaged experimental:contralateral ratios of Pax3+,
Islet1+ or Brn3a cells in Cont/GFP, Pax7/GFP and Pax3/GFP electroporated embryos.
The resulting experimental ratios in Pax3/GFP were significantly different from
Cont/GFP and Pax7/GFP ratios (*P<0.05). Paired t-test was used to generate statistical
significance.
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Table 3. Summary of mis-expression experiment results
Pax3 Mis-expression

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
50
28

Number with normal
expresion in OpV
placode (%)
-

Number with reduced
expresion in OpV
placode (%)
-

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
13
10
13

Average mesenchymal
cell counts
0.431
0.305
0.316

STDEV of
mesenchymal cells
counts
0.311
0.107
0.021

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
21
17

Number with normal
expresion in OpV
placode (%)
-

Number with reduced
expresion in OpV
placode (%)
-

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
8
4
8

Average mesenchymal
cell counts
0.949
0.857
0.844

STDEV of
mesenchymal cells
counts
0.02
0.202
0.063

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
8
10

Number with normal
expresion in OpV
placode (%)
8 (100)
10 (100)

Number with reduced
expresion in OpV
placode (%)
0 (0)
0 (0)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
6
5
6

Average mesenchymal
cell counts
0.967
0.118
0.911

STDEV of
mesenchymal cells
counts
0.11
0.333
0.067

Pax7 Mis-expression

GFP Mis-expression
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Table 3 (cont'). Summary of results of mis-expression experiments
WT Embryos

Gene Analyzed
FGFR4
Ngn2

Total
Number of
Embryos
5
5

Number with normal
expresion in OpV
placode (%)
5 (100)
5 (100)

Number with reduced
expresion in OpV
placode (%)
0 (0)
0 (0)

Gene Analyzed
Pax3
Brn-3a
Islet1

Total
Number of
Embryos
Sectioned
5
5
5

Average OpV placode
cell counts
0.973
1.013
0.919

STDEV of OpV
placode cells
counts
0.08
0.09
0.2
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Figure 14. Whole-mount embryos electroporated with Cont/GFP, Pax7/GFP, and
Pax3/GFP showing GFP targeting (photographed upon embryo collection), and FGFR4
and Ngn2 expression. (A-F) GFP targeting coupled with in situ detection of FGFR4
reveals that Cont/GFP (A, D) and Pax7/GFP (B, E) electroporation do not expand
FGFR4 expression in non-opV placode cranial ectoderm. Pax3/GFP electroporation,
however, does expand FGFR4 expression in cranial ectoderm adjacent to the opV
placode (C, F). (G-L) Whole-mount in situ detection of FGFR4 and Ngn2 in embryos
electroporated with Cont/GFP, Pax7/GFP, and Pax3/GFP. 24 hours after
experimentation, FGFR4 and Ngn2 is not expanded beyond the normal domain in
Cont/GFP (G, J) and Pax7/GFP (H, K) embryos. In embryos electroporated with
Pax3/GFP however, FGFR4 is detected broadly in cranial ectoderm as far caudal as the
first somite (I, brackets). Ngn2 is also detected in Pax3/GFP electroporated embryos,
but only in more caudal ectoderm (L, arrows).
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Table 4. Summary of mis-expression experiments
Pax3 Mis-expression
8 hours

Gene Analyzed
FGFR4
Ngn2

Total Number
of Embryos
N/A
11

Number with no
ectopic expression in
cranial ectoderm (%)
1 (9)

Number with ectopic
expression in
cranial ectoderm (%)
10 (91)

Total Number
of Embryos
N/A
15

Number with no
ectopic expression in
cranial ectoderm (%)
1 (7)

Number with ectopic
expression in
cranial ectoderm (%)
14 (93)

Total Number
of Embryos
50
28

Number with no
ectopic expression in
cranial ectoderm (%)
9 (18)
19 (68)

Number with ectopic
expression in
cranial ectoderm (%)
41 (82)
9 (32)

Total Number
of Embryos
49
50

Number with no
ectopic expression in
cranial ectoderm (%)
40 (82)
46 (92)

Number with ectopic
expression in
cranial ectoderm (%)
9 (18)
4 (8)

15 hours

Gene Analyzed
FGFR4
Ngn2
24 hours

Gene Analyzed
FGFR4
Ngn2
48 hours

Gene Analyzed
FGFR4
Ngn2
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Table 4 (cont'). Summary of mis-expression experiments
Pax7 Mis-expression
8 hours

Gene Analyzed
FGFR4
Ngn2

Total Number
of Embryos
N/A
7

Number with no
ectopic expression in
cranial ectoderm (%)
7 (100)

Number with ectopic
expression in
cranial ectoderm (%)
0 (0)

Total Number
of Embryos
N/A
10

Number with no
ectopic expression in
cranial ectoderm (%)
8 (80)

Number with ectopic
expression in
cranial ectoderm (%)
2 (20)

Total Number
of Embryos
21
17

Number with no
ectopic expression in
cranial ectoderm (%)
19 (90)
17 (100)

Number with ectopic
expression in
cranial ectoderm (%)
2 (10)
0 (0)

Total Number
of Embryos
18
17

Number with no
ectopic expression in
cranial ectoderm (%)
16 (89)
17 (100)

Number with ectopic
expression in
cranial ectoderm (%)
2 (11)
0 (0)

15 hours

Gene Analyzed
FGFR4
Ngn2
24 hours

Gene Analyzed
FGFR4
Ngn2
48 hours

Gene Analyzed
FGFR4
Ngn2
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Table 4 (cont'). Summary of mis-expression experiments
GFP Mis-expression
8 hours

Gene Analyzed
FGFR4
Ngn2

Total Number
of Embryos
N/A
7

Number with no
ectopic expression in
cranial ectoderm (%)
7 (100)

Number with ectopic
expression in
cranial ectoderm (%)
0 (0)

Total Number
of Embryos
N/A
10

Number with no
ectopic expression in
cranial ectoderm (%)
10 (100)

Number with ectopic
expression in
cranial ectoderm (%)
0 (0)

Total Number
of Embryos
8
10

Number with no
ectopic expression in
cranial ectoderm (%)
8 (100)
10 (100)

Number with ectopic
expression in
cranial ectoderm (%)
0 (0)
0 (0)

Total Number
of Embryos
7
8

Number with no
ectopic expression in
cranial ectoderm (%)
7 (100)
8 (100)

Number with ectopic
expression in
cranial ectoderm (%)
0 (0)
0 (0)

15 hours

Gene Analyzed
FGFR4
Ngn2
24 hours

Gene Analyzed
FGFR4
Ngn2
48 hours

Gene Analyzed
FGFR4
Ngn2
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Figure 15. Transverse sections of embryos electroporated with Pax3/GFP and collected
24 and 48 hours after experimentation. (A-D) Pax3 mis-expression does not cause Islet1
(green) expression between 24 hours (A, A’) and 48 hours (B, B’), or Brn-3a (green)
expression between 24 hours (C, C’) and 48 hours (D, D’). Even though Islet1 is
expressed in some cranial ectoderm, it is not co-expressed with Pax3 mis-expression (A,
A’, arrows). Brn-3a expression can be seen in the dorsal neural tube after 48 hours, but
is not expressed in the cranial ectoderm with Pax3 mis-expression (D, D’).
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Pax3-inducing signal from the neural tube (Baker et al., 1999). Cont/GFP and
Pax7/GFP vectors were again used for control embryos. Embryos were collected 8, 15,
24 and 48 hours after electroporation and prepared for in situ hybridization (to detect
FGFR4 and Ngn2) or immunohistochemistry (to detect Pax3, Pax7, Brn-3a, and Islet1).
The earliest markers of the opV placode other than Pax3 are FGFR4 and Ngn2 (Stark et.
al. 1997, Begbie et. al. 2002). Electroporated embryos were therefore analyzed for
FGFR4 and Ngn2 expression by in situ hybridization; targeted regions were identified by
comparing “before” and “after” whole-mount pictures of each embryo (compare Fig.14A,
D; 14B, E; and 14C, F). While ectopic expression of FGFR4 or Ngn2 was not seen in
Cont/GFP or Pax7/GFP electroporated embryos, embryos collected 8-15 hours after
electroporation with Pax3/GFP showed obvious ectopic expression of FGFR4 (n = 10).
In addition, Ngn2 could be detected strongly in cranial ectoderm caudal to the opV
placode (n = 36). In embryos collected 24 hours after Pax3/GFP electroporations,
ectopic FGFR4 was still easily detected in cranial ectoderm (n = 50; Fig.14I), but ectopic
Ngn2 was seen only in a few cells and only in ectoderm caudal to the otic vesicles (n =
28; Fig.14L). Cont/GFP and Pax7/GFP control embryos again showed no ectopic
expression of FGFR4 (Fig.14G, H) or Ngn2 (Fig.14J, K). In embryos collected 48 hours
after electroporation, most or all endogenous opV placode cells had delaminated and
ganglion condensation was obvious. Endogenous FGFR4 and Ngn2 are therefore no
longer expressed, since both markers are downregulated in migratory placode cells.
Therefore, it was expected that experimental and control embryos collected 48 hours
after electroporation showed no FGFR4 or Ngn2 expression in targeted cranial ectoderm
(Pax3/GFP, n = 99; Pax7/GFP, n = 35; Cont/GFP, n = 10), though both genes were
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expressed as expected in other embryonic tissues, verifying that the in situ hybridization
protocol worked properly (data not shown). Immunohistochemistry on embryo sections
verified ectopic Pax3 or Pax7 protein expression in cranial ectoderm in embryos that
were subject to in situ hybridization for FGFR4 and Ngn2 (data not shown). Analysis of
these sections also confirmed that neither FGFR4 nor Ngn2 was expressed in the cranial
ectoderm of embryos electroporated with Pax3/GFP or Pax7/GFP (data not shown).
Similarly, embryos electroporated with Cont/GFP showed no FGFR4 or Ngn2 gene
expression in the opV placode or adjacent cranial ectoderm (data not shown).
Ectopic Pax3/GFP expression was shown to upregulate FGFR4 and Ngn2 in
non-opV cranial ectoderm at varying levels between 8-24 hours after electroporations.
We next wanted to learn if additional opV-placode markers were upregulated in
response to Pax3 expression in non-opV cranial ectoderm. In embryos collected 24
hours after electroporation there was no observable Islet1 (Fig.15A, A’) or Brn-3a
(Fig.15C, C’) expression in ectopic Pax3+ or GFP+ cells. Pax3 was detectable in
embryos collected 48 hours after Pax3/GFP electroporation, but Islet1 (Fig.15B, B’)
and Brn-3a (Fig.15D, D’) expression were not detected in targeted cells. Thus, sensory
neuron differentiation as determined by Islet1 and Brn-3a expression does not occur in
targeted cells. To summarize, expression of Pax3 in non-opV cranial ectoderm leads to
the sustained upregulation of FGFR4, and the transient upregulation of Ngn2. Brn-3a
and Islet1 were not upregulated in targeted cells.
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Discussion
The cell-autonomous function of Pax3 in opV placode development had not
previously been investigated. From expression data, and from casual observations of
Splotch phenotypes (Tremblay et al., 1995; Stark et al., 1997), it was evident that Pax3
might be critical for the development of these cells. Designing experiments toward
answering the question of Pax3 function in the opV placode proved challenging,
however, because nearby tissues involved in opV placode and ganglion development
like the neural crest and neural tube also express Pax3, are compromised in Splotch
mutants. It was therefore unclear whether Pax3 plays a cell-autonomous role in opV
placode development. In this study we used tissue-specific targeting to knockdown or
mis-express Pax3. We then examined the expression of several downstream markers
of opV placode development to determine whether Pax3 is necessary and sufficient for
the development of opV placode cells.

Pax3 is necessary for opV placode development and placode-derived sensory neuron
contribution to the trigeminal ganglion.
Our results show that inhibiting Pax3 within the opV placode domain using
gene-specific morpholinos (p3MO) will stop normal opV placode development as
assayed by various placodal markers (FGFR4, Ngn2, Brn-3a and Islet1). FGFR4 and
Ngn2 were analyzed by whole mount in situ hybridization, and the reduction was
qualitatively striking (Fig.6C, F). Cross sectional analysis of these embryos revealed
that Pax3 protein expression was indeed lost. We were pleased with the high targeting
efficiency using the morpholino. Most of the cells appeared targeted immediately after

57

electroporation (as determined by visualization of the fluorescently labeled morpholino),
and placodal expression of FGFR4 and Ngn2 was mostly or completely absent in the
targeted placode. Immunohistochemical analysis of cell nuclei stained for Pax3, Brn-3a,
and Islet1 in the placode regions showed a dramatic reduction in the number of cells
expressing placode markers in experimental embryos.
While our qualitative observations were convincing, experimental variables such
as tissue targeting by electroporation led to subtle but distinct differences from embryo to
embryo. We therefore devised a standard way to confirm statistically that we were
indeed observing a difference. Cell counts through the entire opV placode domain of a
few embryos allowed us to quantitatively compare knockdown and control embryos.
Counts of control (cMO) embryos demonstrated the equivalence of left and right placodes
in the absence of gene manipulation, as slight differences were not statistically significant
when compared with WT embryos (p>0.4 for all opV placode markers). Experimental
knockdown of Pax3 using the p3MO, however, led to a significantly reduced number of
cells expressing each of the opV placode markers compared to the contralateral placode
(see Fig.8). Because the loss of markers was so dramatic, only a fraction of the total
experimental embryos needed to be analyzed statistically to reach our conclusions that
the difference was quantitatively significant. Because experimental knockdown of Pax3
resulted in a significant reduction of downstream markers, our hypothesis that Pax3
protein expression in placode cells is necessary for proper opV placode sensory neuron
development is supported. The phenotype generated from these knockdown experiments
was similar to that of the Splotch mice phenotype, in that the trigeminal ganglion is
reduced. However, the role of Pax3 in regulating genes within the opV trigeminal
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placode is uncertain. Previous research showed that neural tube defects in Splotch mice
are associated with neuroepithelial apoptosis (Phelan et al., 1997). However, antisense
oligonucleotide down-regulation of Pax3 in neural crest cultures inhibited sensory neuron
differentiation without affecting survival of sensory neurons or precursor populations
(Koblar et al., 1999), so it is difficult to determine if the observed phenotype is caused by
cell death or direct gene regulation. Further investigation is required to determine if Pax3
expression is related to expression of opV placode-specific genes, and that loss of opV
placode cells is not due to apoptosis rather than a lack of induction.

Pax3 mis-expression with or without p3MO is sufficient for upregulation of some opV
placodal markers, but insufficient for complete neuronal differentiation
In our experimental design, we hypothesized that co-electroporation of
p3MO+Pax3/GFP within the opV placode domain would rescue the placodal phenotype.
While we found that Pax3 expression was restored, we discovered that some downstream
targets were not rescued, and normal opV placode development was interrupted. The
loss of migratory opV placode cells was statistically significant (p<0.05) compared to
controls, similar to what was observed in embryos electroporated with p3MO alone. Our
data show that while Pax3 is necessary for FGFR4, Ngn2, Brn-3a and Islet1 expression
in the opV placode (as determined by p3MO experiments), there must be other factors
or conditions that need to be met for proper gene regulation and placodal differentiation.
FGFR4 was the only gene rescued in the opV placode domain with co-electroporation.
In these experiments, embryos were not assayed earlier than 24 hours after
electroporation, therefore transient expression of genes such as Ngn2 cannot be ruled out.
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This is likely the case only for Ngn2 as predicted by our ectopic Pax3 mis-expression in
non-opV cranial ectoderm.
To better assess the effects of Pax3 mis-expression on opV placode development,
a more detailed approach was taken in experiments aimed at determining whether ectopic
Pax3 is sufficient for complete opV placode cell development. A broad region of
ectoderm was evaluated, and embryos were collected at several time points to evaluate
possible transient expression of placodal markers. Consistent with the co-electroporation
results, we observed no expression of Brn-3a or Islet1 in non-opV placode cranial
ectoderm, and significant loss of these markers in the opV placode domain. It appeared
though that FGFR4 was robustly expressed in cranial ectoderm as far caudal as the first
somite in response to Pax3 mis-expression. The expression pattern of Ngn2 in response
to Pax3 mis-expression, however, was more complex. Shortly after Pax3 was misexpressed (8-15 hours after electroporation), Ngn2 was strongly expressed in cranial
ectoderm. However, 24 hours after Pax3 electroporations, Ngn2 was only minimally
expressed in more caudal ectoderm. Upon closer evaluation, it became clear that
transient expression of FGFR4 and Ngn2 is normal. During development of the opV
placode, FGFR4 and Ngn2 mRNA can be visualized at high levels between 9-12 hours
after initial Pax3 expression (Begbie et al., 2002; Stark et al., 1997), but are
downregulated as the opV placode cells delaminate and migrate from the ectoderm into
the mesenchyme. Since Ngn2 and FGFR4 expression patterns are virtually identical
during normal opV placode development, we would have expected the same response to
Pax3 mis-expression. Surprisingly, transient Ngn2 expression in response to Pax3 misexpression in cranial ectoderm was shorter than FGFR4 expression.
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When designing the ectopic Pax3 expression experiments described here, we
hypothesized that targeted cells would follow similar fate changes as observed in the
endogenous placode, such as sustained Pax3 expression, transient FGFR4 and Ngn2
expression around the time of EMT, and upregulation of the other downstream markers
(Stark et al. 1997; Begbie et al. 2002). While we did observe sustained Pax3 expression
(driven by the Pax3/GFP vector) and transient FGFR4 and Ngn2 expression, the steps of
EMT and continued differentiation are lost. The failure of targeted cells to delaminate
and migrate might be explained by the fact that NCAM is a known target for Pax3
(Mayanil et al., 2001). Over-expression of Pax3 protein has been shown to be directly
responsible for increased adhesion properties. Though this explains why targeted cells do
not migrate, it still does not explain why Pax3 expression alone, even in competent
ectoderm, is not independently sufficient to produce a fully differentiated sensory neuron.
Additionally, high levels of Pax3 are formed endogenously in placode cells undergoing
EMT, which contradicts a specific role for Pax3 in increased adhesion. There are a few
possible explanations for this. For example, in many developmental processes, cellular
induction is a cumulative process, wherein cells receive precise signals from surrounding
tissues over time. The nature and timing of each signal is vital in ensuring a proper
outcome. In the opV placode, a diffusible signal from the neural tube interacts with the
ectoderm and activates expression of placode genes, including Pax3, and subsequent
formation of the opV placode (Stark et al. 1997; Baker et al, 1999). Since sustained Pax3
expression is insufficient for complete placodal cell differentiation, other genes may be
independently upregulated by the induction process, which provides full placodal
specification. This suggests that while Pax3 has been described as a marker of
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committed cells, it is insufficient for full commitment. However, expression data within
the opV placode domain argues against this. Pax3 over-expression within the opV
placode domain, where endogenous Pax3 is expressed, results in a loss of migratory
placode cells (see Fig.8). If additional co-factors were the only requirement, then one
would expect normal opV placode development in the endogenous placode domain, even
with increased Pax3 expression.
A more plausible explanation involves the timing of gene expression, since Pax3
expression in explanted opV ectoderm correlates with neuronal specification and with
commitment to an opV fate (Baker and Bronner-Fraser, 2000). For example, in normal
embryos, endogenous placodal Pax3 expression can be seen in a broad area of surface
ectoderm at about the 8-ss. Expression becomes more restricted and intense near the 1216ss (Stark et al. 1997). As the opV placode becomes more defined and endogenous
Pax3 is expressed at higher levels, the cells become committed to a sensory neuron fate
and can no longer be influenced by external factors. This seems to be a stepwise process,
with a few cells being committed early, and more cells being recruited throughout the
described stages (Baker et al., 1999). If cells within the opV placode domain are
experimentally driven to express high levels of Pax3 before they transition through other
appropriate steps (as happened in this study), it may partially short circuit their ability to
adopt a neuronal cell fate. Upregulation of FGFR4 and Ngn2 is not affected and happens
normally, but continued differentiation into sensory neurons is somehow blocked. The
similar outcome in adjacent cranial ectoderm would also fit this explanation.
A final explanation includes a qualitative observation of the spatiotemporal
expression pattern of Pax3. Early endogenous Pax3 protein expression is observed
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throughout a broad domain of cranial ectoderm adjacent to the midbrain. The expression
level at early stages is about equivalent to the expression level in the adjacent neural
folds, except for a few highly expressing cells. Gradually the number of cells expressing
Pax3 robustly increases in the opV placode domain, and the field appears to become
more refined. In whole-mount in situ hybridization of Pax3, and in
immunohistochemistry on embryo sections, cells expressing lower levels of Pax3, and
cells negative for Pax3 can be observed (Stark et al., 1997; M.R.S., unpublished
observations). Cell-cell interactions between Pax3-positive and Pax3-negative cells may
be necessary for proper cellular differentiation. Pax3 may set up the pattern, or may be
regulated within the field by such interactions. Our experimental paradigm of Pax3 misexpression, where strong expression levels in multiple adjacent cells were observed, may
have prevented normal neuronal identity development. The obvious candidate pair for
this juxtacrive cell-cell signaling is Notch-Delta. Delta-1 (a ligand for Notch signaling) is
transiently expressed in the opV placode concomitant with Ngn2 expression and is
restricted to individual cells within the placodal ectoderm (Begbie et al., 2002), providing
expression data in support of this hypothesis. We are currently investigating the
spatiotemporal expression of Pax3 positive cells within the developing opV placode. We
also plan to modify our electroporation technique in future studies so that a more
scattered Pax3 expression pattern is achieved instead of the robust targeting of most cells
in an area.
In conclusion, our data show that Pax3 is necessary for normal opV placode cell
development. The data also show that Pax3 is sufficient to induce FGFR4 and Ngn2
expression in competent cranial ectoderm, further indicating that Pax3 is an important
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participant in specifying opV placode cells. However, since complete neurogenesis was
not observed after ectopic Pax3 expression, and since Pax3 mis-expression caused a loss
of endogenous placode cells, we cannot conclude that Pax3 alone is sufficient for opV
placode development. While further investigation will need to elucidate the possible
mechanisms and/or co-factors required for complete opV placode development, our study
demonstrates a central role for Pax3 in the proper development of opV placode cells.
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Chapter 2
Introduction
The patterns of gene expression during neural tube development establish the
anterior-posterior and dorsoventral boundaries. The division of the neural tube into
dorsal and ventral regions occurs by receiving opposing signals from the epidermal
ectoderm and the notochord, respectively, to specify the fate of cells along the
dorsoventral axis (Placzek, 1995; Dickinson et al., 1995; Tanabe and Jessell, 1996).
Some of the inductive signals involved in dorsoventral (DV) patterning of the neural tube
are bone morphogenetic proteins (BMPs) and Sonic hedgehog (Shh) (Jessell, 2000; Lee
and Jessell, 1999). Research shows that BMPs are able to induce dorsal neuronal cell
types in vitro (Lee and Jessell, 1999). The signaling molecules involved in setting up the
DV axis in the neural tube do so by incurring changes in the expression of transcription
factors. Two of these transcription factors, the Pax family homeodomain factors Pax3
and Pax7, are expressed at early neural plate stages and becomes restricted to the dorsal
half of the neural tube in response to repressive signals from Shh (Liem et al., 1997).
Previous research shows that Pax3 and Pax7 are induced by BMPs, and that ectopic
expression of BMP can induce Pax3 expression in the basal floor plate, resulting in an
absence of motorneuron differentiation (Monsoro-Burq et al., 1996; Liem et al., 1997). It
has been proposed that there is a functional redundancy between Pax3 and Pax7 in tissues
where they are co-expressed such as muscle precursors (Relaix et al., 2005) and the
neural tube (Mansouri et al., 1998). Although their domains of expression largely
overlap, Pax7 has a lower expression in the most dorsal regions in mice in the neural tube
and somites. Previous research shows that neural tube defects in Splotch (Pax3 null)
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mice are associated with neuroepithelial apoptosis (Phelan et al., 1997). Functional
redundancy is supported by the fact that Pax7 is upregulated in Splotch mice, and its
expression becomes expanded into the dorsal neural tube and somites, where cell survival
is maintained and Pax3 would normally be expressed (Borycki et al., 1999). Analysis of
the Pax3/Pax7 double mutant embryos reveal their function in restricting ventral neuronal
identity and their requirement in cells that give rise to a subset of commissural
interneurons (Mansouri and Gruss, 1998).
There are many factors that mark dorsal interneuron progenitors as they
differentiate within the dorsal neural tube. Math1 is a neural basic Helix-Loop-Helix
(bHLH) transcription factor that induces neuronal differentiation as defined by cell cycle
exit, translocation of the cells laterally out of the ventricular zone, and subsequent
expression of neuronal markers. Over-expression studies of Math1 suggest that contextdependent protein-protein interactions within a restricted domain are important for its
distinct function (Gowan et al., 2001; Nakada et al., 2004). LIM-homeodomain proteins
Lhx1/5 and Islet1 are known to mark different populations of dorsal interneurons (dI) and
ventral interneurons (V) as well as motorneurons in the neural tube. Lhx1/5 marks the
dI2, 4, 6, V0, and V1 populations while Islet1 marks the dI3 and motoneuron populations
(Liu et al., 2004; Helms and Johnson 2003). Previous research shows the necessity of
Islet1 in the generation of motorneurons (Pfaff et al., 1996). The POU domain
transcription factor Brn-3a marks dI1, 2, 3, and 5 populations and is not found in dividing
neuroblasts in the ventricular germinal zone, but in a subset of post-mitotic neurons
(Helms and Johnson 2003; Ninkina et al., 1993). Research shows that even though Brn3a is expressed in post-mitotic neurons, it supports a critical role in the specification of
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Figure 16. Neural Tube Development
The figure above (half of the dorsal neural tube) portrays the genes expressed during the
differentiation of neuronal subtypes. It is not known if Pax3 in expressed in these early
neuronal progenitors as no published data is available that has looked at cell specific
expression of Pax3 with these interneurons. Though Pax7 has been shown to be
expressed in many neuronal progenitors, it is unclear what the function of Pax7 is in
interneuron differentiation. It is assumed since Pax3 and Pax7 share redundant functions
and have similar expression patterns, that Pax3 is also expressed in these early progenitor
cells. Information related to the drawing of this diagram was taken from Helms and
Johnson, 2003.
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the mature neuronal phenotype (Fedtsova and Turner, 1996). All of these factors
contribute to distinct domains of neuronal differentiation that are essential for proper
neural tube development and interneuron specification.
Though it is clear that Pax3 and Pax7 are necessary for restricting ventral
neuronal identity and are required in cells that give rise to a subset of commissural
interneurons (Mansouri and Gruss, 1998), it is unclear the precise role that both of these
genes have on dorsal interneuron cell fate within the neural tube. We wish to understand
the relationship between the various molecular markers of dorsal interneuron populations
and the cell autonomous expression of Pax3 and Pax7 in the neural tube. We have
unilaterally targeted dorsal and ventral neural tube using Pax3 and Pax7 mis-expression
vectors. We found that Pax3 and Pax7 mis-expressions were able to stop motorneuron
differentiation in the ventral neural tube independent of BMP signaling. We also found
that Pax3 and Pax7 mis-expressions stopped dorsal interneuron differentiation (as
assayed by downstream markers), when continued expression within the mantle zone was
maintained. We observed that overexpressions of Pax3 and Pax7 were not sufficient to
cause increased commissural neuron expression.
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Materials and Methods
Production of Pax3, Pax7, and Control Mis-expression Vectors
A pCL-GFP vector was obtained from Dr Christophe Marcelle (Developmental
Biology Institute, Marseille) which contains a polylinker flanked by a CMV promoter,
and a separate region containing the SV40 promoter driving GFP (Scaal et. al. 2004). For
our experiments, this vector was modified by replacing the CMV promoter and the
associated intron sequence with the RSV promoter sequence from pRc/RSV (Invitrogen).
This modified vector (named Cont/GFP) was used for electroporation controls. Full
length chicken Pax3 cDNA, obtained from Eiji Matsunaga (Matsunaga et. al. 2001), was
inserted into the modified vector (named Pax3/GFP). Because of proposed functional
redundancy between Pax3 and Pax7 in tissues where they are co-expressed such as
muscle precursors (Relaix et al., 2005) and the neural tube (Mansouri et al., 1998), Pax7
was used to test whether Pax3 and Pax7 had similar properties when mis-expressed in
surface ectoderm. The Pax7 mis-expression vector (named Pax7/GFP) used for controls
was kindly provided by Laura Burrus.

In Ovo Electroporations
Fertilized chicken eggs from a local farm were incubated in a humidified
atmosphere at 37.5ºC. Pax3, Pax7, or control electroporation vectors (5.0 µg/µl), Pax-3
morpholinos or standard control morpholinos (5.0 µg/µl) were introduced into target
tissues by in ovo electroporation as described by Van Raay and Stark (2002). Eggs were
windowed using standard techniques in preparation for electroporations. PBS/0.5%
Penn-strep was used to keep area around embryo from drying and reducing chance of
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bacterial growth during development after manipulation. Briefly, electrodes were placed
on opposing sides of the embryo. Vector DNA was injected adjacent to target tissue and
a current was applied using a square pulse electroporator (BTX). The following
parameters were used for all electroporations: 5 pulses, 12V, 10msec/pulse. After target
tissue was electroporated, the embryo was again washed in PBS/Penn-strep, sealed, and
placed in the incubator to continue development.

Immunohistochemistry
Embryos were collected after 8 to 48 hours of incubation post-electroporation, fixed in
4% formaldehyde for 1 hour at room temperature and processed for cryostat sectioning as
described by Sechrist et al. (1995). 12-16 µm sections were mounted on Superfrost® Plus
glass slides (Fisher) and the gelatin removed by treating the slides in phosphate-buffered
saline (PBS) at 37°C for 15 minutes. Slides were incubated overnight at 4°C in primary
antibody solution, and 1 hour in secondary antibody solution at RT, with three 5-minute
washes after incubation with each antibody solution. Slides were mounted in
Fluoromount-G (Southern Biotechnology Associates, Inc.) and viewed by fluorescent
microscopy. Antibodies were diluted in antibody buffer consisting of 0.1% BSA and
0.1% Triton in PBS. Table 1 lists the primary antibodies used in this study, the dilutions
used, their sources, and appropriate references. Subtype-specific Alexa350-, Alexa488-,
Alexa546-, and Alexa633-conjugated secondary antibodies were obtained from
Molecular Probes and used as secondary antibodies.
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Analysis of Neural Tube Cell Counts
Individual cell counts within the neural tube were necessary to analyze statistical
significance between experimental and control embryos. To quantitatively compare
electroporated versus contralateral neural tube cells, select embryos were photographed
and cells expressing the marker of interest were counted on both electroporated and
contralateral sides through the neural tube region electroporated. This was expressed as a
ratio (for each embryo) of the total number of cells expressing a marker of interest on the
electroporated side, divided by the total number of contralateral (control) cells expressing
the marker of interest. By averaging the mean ratios of all embryos counted in each
experimental group, the average and standard deviation were calculated. A t-test was
used to compare the average and standard deviation of experimental embryos to control
embryos. Averages and standard deviations from WT mean ratios were calculated and
compared to experimental embryos to test for statistical significance.
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Results
Because of the proposed functional redundancy of Pax3 and Pax7, we wanted to
analyze their spatiotemporal expression patterns at key stages of development.
Immunohistochemical staining of wildtype (WT) embryos with Pax3 and Pax7 was
performed to verify the expression patterns and ensure that our staining protocol could
visualize both genes (Fig.17). We observed that Pax3 and Pax7 were restricted to the
dorsal neural tube and that expression of Pax3 was not present in the roof-plate of the
neural tube at later stages. Figure 17 reveals the WT expression pattern of Pax3 and Pax7
in the neural tube at stages 12, 20, and 23 (equivalent to the stages that embryos were
collected after electroporations). Pax3 (Fig.17 A, B) and Pax7 (Fig.17 A’, B’) expression
remains restricted to the dorsal neural tube, but at the later stages they also become
restricted to the ventricular zone, and are no longer expressed in the outer mantle zone
(Fig.17 C, C’). Overlay of Pax3/Pax7 expression reveal that most cells are co-expressing
as the neural tube develops (Fig.17 D-F). Though endogenous Pax7 expression is lower
than endogenous Pax3 expression in the roof-plate of mice, it appears that in chick the
expression patterns are reversed (Fig.17 C, C’, arrows).
Our experimental aims to compare electroporated and non-electroporated sides of
the neural tube required unilateral targeting of the neural tube. GFP visualization of
targeted cells allowed us to determine appropriate targeting of the neural tube at various
stages. Electroporations of embryos revealed that though some ectoderm was targeted
(Fig.18A), the neural tube was effectively targeted unilaterally (Fig.18B). Axons can be
seen projecting from cells targeted both dorsally and ventrally (Fig.18C).
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Pax3 and Pax7 mis-expression stop motorneuron differentiation
As mentioned before, ectopic expression of BMP can induce Pax3 expression in
the basal floor plate, resulting in an absence of motorneuron differentiation (MonsoroBurq et al., 1996; Liem et al., 1997). Our first aim was to determine if loss of
motorneuron differentiation in the basal floor plate was due a combination of factors
initiated by BMP signaling, or if Pax3 expression alone was sufficient. Pax3/GFP and
Pax7/GFP were electroporated separately and together to determine if motorneuron Islet1
expression was affected. As expected, qualitative analysis of WT embryos showed equal
numbers of Islet1 cells between left/right neural tube (Fig.19A, F, K). Cont/GFP
electroporations revealed little or no visible knockdown of Islet1 expression at 24, 48, or
72 hours after electroporations (Fig.19B, G, L). Qualitative analysis of Pax3/GFP and
Pax7/GFP electroporations revealed that were both able to individually and collectively
knockdown Islet1 expression 24, 48, and 72 hours after electroporations (Pax3, Fig.19C,
H, M; Pax3/7, Fig.19D, I, N; Pax7, Fig.19E, J, O). Because of variability due to
timing of experimentation and targeting success, we concluded that the best approach to
quantitatively determine the effects of mis-expressing Pax3 and Pax7 on neuronal
differentiation was to compare the experimental neural tube with the contralateral neural
tube, and report the ratio of cells expressing a given marker (Fig.20). Quantitative ratios
were calculated as described in the methods section of this study. Values reported here
are in the format (average ratio ± standard deviation). WT averages for Islet1+ cells at
24 hours (0.960 ± 0.059), 48 hours (0.942 ± 0.041), and 72 hours (0.987 ± 0.052) showed
relatively equal cell ratios between left/right neural tube. Embryos electroporated with
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Figure 17. Pax3 and Pax7 endogenous expression in neural tube. Immunostained
sections of wildtype embryos showing Pax3 (red) and Pax7 (green) protein expression in
the neural tube at stages 12, 20, and 23. Though Pax3 and Pax7 have overlapping
expression patterns in the dorsal neural tube at earlier stages of development (A, A’, D ,
B, B’, E), Pax7 appears to have higher expression in the most dorsal region of the neural
tube at later stages (C, C’, arrows). Overlay pictures reveal that both Pax3 and Pax7
maintain a similar pattern of expression even at later stages (F).
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Figure 18. GFP visualization of neural tube electroporations. Chick embryo
electroporated with Cont/GFP showing GFP targeting. Targeting of neural tube can be
visualized in both lateral (A) and dorsal (B) views. Transverse section of neural tube
reveals unilateral targeting of neural tube and integration of GFP into axon projections
(C).
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Figure 19. Immunohistochemistry on transverse sections through the neural tube show
downregulation of Islet1 in response to Pax3/GFP, Pax3/GFP + Pax7/GFP, and
Pax7/GFP electroporations after 24, 48, and 72 hours. In all panels, left is the control
side, and right is the electroporated side of the embryo. (A, B, F, G, K, L)
Immunofluorescence staining of WT and Cont/GFP cross sections showing expression of
Pax3 (red in A, F, K), GFP (pseudocolored red in B, G, L), and Islet1 (green) in the
neural tube 24, 48, and 72 hours after electroporations. WT and Cont/GFP sections show
equal levels of Islet1 expression between left/right sides of neural tube at all time points.
However, immunofluorescent staining of Pax3 (red in C, D, H, I , M, N), Pax7 (red in E,
J, O), and Islet1 (green) in embryos electroporated with Pax3/GFP, Pax3/GFP +
Pax7/GFP, and Pax7/GFP reveal that Islet1 positive cells are downregulated in response
to mis-expression of Pax3 and/or Pax7 in the ventral neural tube at all time points.
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Figure 20. Graph showing the averaged right:left ratios of Islet1+ cells in the WT neural
tube, and the averaged experimental:contralateral ratios of Islet1+ cells in Cont/GFP,
Pax3/GFP, Pax3/GFP + Pax7/GFP, and Pax7/GFP electroporated embryos after 24, 48,
and 72 hours post-electroporation. The resulting Pax3/GFP, Pax3/GFP + Pax7/GFP, and
Pax7/GFP ratios were significantly different from WT and Cont/GFP ratios (*P<0.05).
Paired t-test was used to generate statistical significance.

Figure 21. GFP visualization of control electroporations show commissural neuron axons
projecting across the ventral midline (arrows). Pax3 electroporations did not cause
ectopic commissural neuron expression as visualized by GFP expression.
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Table 5. Summary of Islet1 neural tube staining results
Islet1
24 hours
Average
STDEV of
ventral neural
ventral neural
Total Number of
Gene
Embryos
tube cell
tube cells
Analyzed
counts
counts
Sectioned
WT
3
0.96
0.059
GFP
5
0.927
0.228
Pax3
5
0.521
0.092
Pax3/7
7
0.476
0.153
Pax7
7
0.579
0.057
Islet1
48 hours

Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7

Total Number of
Embryos
Sectioned
4
4
5
5
4

Average
ventral neural
tube cell
counts
0.942
0.917
0.498
0.306
0.382

STDEV of
ventral neural
tube cells
counts
0.02
0.053
0.039
0.134
0.128

Total Number of
Embryos
Sectioned
3
4
4
4
4

Average
ventral neural
tube cell
counts
0.987
0.862
0.541
0.506
0.362

STDEV of
ventral neural
tube cells
counts
0.032
0.125
0.129
0.073
0.141

Islet1
72 hours

Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7
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Cont/GFP were stained and analyzed, revealing that the averages were not significantly
different from WT neural tube cell ratios for Islet1+ cells at 24 hours (0.927 ± 0.228;
p=0.769), 48 hours (0.917 ± 0.053; p=0.411), and 72 hours (0.862 ± 0.125; p=0.113) after
electroporations. In embryos electroporated with Pax3/GFP, the neural tube cell ratios
for Islet1+ cells at 24 hours (0.521 ± 0.092), 48 hours (0.498 ± 0.039), and 72 hours
(0.541 ± 0.129) were significantly different from the control Cont/GFP and WT results
(p<0.05 for all time points). Pax7/GFP electroporations also showed similar reduction of
endogenous Islet1+ cells after 24 hours (0.579 ± 0.057), 48 hours (0.382 ± 0.128), and 72
hours (0.362 ± 0.141) when compared with controls (p<0.05 for all time points).
Embryos electroporated with both Pax3/GFP and Pax7/GFP also showed a significant
reduction in Islet1+ cells at 24 hours (0.476 ± 0.153), 48 hours (0.306 ± 0.134), and 72
hours (0.506 ± 0.073) when compared with controls (p<0.05 for all time points). These
results revealed that independent of BMP signaling in the ventral neural tube, Pax3 and
Pax7 both have the ability individually and collectively to downregulate Islet1 expression
in motorneurons at several stages of development.

Mis-expression of Pax3 and Pax7 do not cause ectopic expression of commissural
neurons
Previous research shows that Pax3 and Pax7 are required in cells that give rise to
a subset of commissural neurons (Mansouri and Gruss, 1998). We wanted to determine
if over-expression of Pax3 and Pax7 individually and collectively in the dorsal and
ventral neural tube leads to an increase in commissural interneuron expression.
Analyzing GFP expression we observed in Cont/GFP electroporated embryos that
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targeted commissural neurons projected their axons towards the ventral neural tube and
crossed the ventral midline. However, we did not observe any projection of axons
expressing GFP in embryos electroporated with Pax3 and Pax7 (Fig. 21). We also used
neurofilament staining to visualize commissural axons. WT embryos were used to match
endogenous expression levels with electroporated stages (Fig.22A, F, K). Cont/GFP
experimental embryos showed normal expression in commissural interneurons at 24, 48,
and 72 hours after electroporation of 5-10 somite stage embryos (Fig.22B, G, L).
Qualitative analysis of neurofilament staining revealed that mis-expression with Pax3 and
Pax7 individually and collectively showed no increase in commissural interneuron
expression at 24, 48, and 72 hours after electroporations (Pax3, Fig.22C, H, M; Pax3/7,
Fig.22D, I, N; Pax7, Fig.22E, J, O). Even though staining of neurofilament in
commissural interneurons revealed no change in expression levels, it was difficult to
quantitatively assess whether there was an increase or not, since individual cells cannot
be counted.

Mis-expression of Pax3 and Pax7 causes downregulation of dorsal interneuron
progenitors
It has been shown that commissural interneuron populations originate from dI1
and dI2 populations which express both Brn-3a and Lhx1/5 (Helms and Johnson 2003).
To better quantify the effects of Pax3 and Pax7 on commissural interneuron
differentiation, we stained for Brn-3a and Lhx1/5 and collected embryos 24, 48, and 72
hours after electroporations. Qualitative analysis of embryos electroporated and collected
24 hours later revealed that endogenous levels of Brn-3a or Lhx1/5 in WT embryos
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Figure 22. Immunohistochemistry on transverse sections through the neural tube
showing no change in neurofilament staining in response to Pax3/GFP, Pax3/GFP +
Pax7/GFP, and Pax7/GFP electroporations after 24, 48, and 72 hours. In all panels, left
is the control side, and right is the electroporated side of the embryo. (A, B, F, G, K, L)
Immunofluorescence staining of WT and Cont/GFP cross sections showing expression of
Pax3 (red in A, F, K), GFP (pseudocolored red in B, G, L), and neurofilament (green) in
the neural tube 24, 48, and 72 hours after electroporations. WT and Cont/GFP sections
show equal levels of neurofilament staining between left/right sides of neural tube at all
time points. Immunofluorescent staining of Pax3 (red in C, D, H, I , M, N), Pax7 (red in
E, J, O), and neurofilament (green) in embryos electroporated with Pax3/GFP,
Pax3/GFP + Pax7/GFP, and Pax7/GFP reveal that no change occurs in neurofilament
staining in response to mis-expression of Pax3 and/or Pax7 in the dorsal neural tube at all
time points.
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Figure 23. Immunohistochemistry on transverse sections through the neural tube show
downregulation of Brn-3a in response to Pax3/GFP, Pax3/GFP + Pax7/GFP, and
Pax7/GFP electroporations after 48 and 72 hours. In all panels, left is the control side,
and right is the electroporated side of the embryo. (A, B, F, G) Immunofluorescence
staining of WT and Cont/GFP cross sections showing expression of Pax3 (red in A, F),
GFP (pseudocolored red in B, G), and Brn-3a (green) in the neural tube 48 and 72 hours
after electroporations. WT and Cont/GFP sections show equal levels of Brn-3a
expression between left/right sides of neural tube at both time points. Immunofluorescent
staining of Pax3 (red in C, H), Pax7 (red in E, J), and Brn-3a (green) in embryos
electroporated with Pax3/GFP or Pax7/GFP reveal that Brn-3a positive cells are
downregulated in response to mis-expression of Pax3 or Pax7 in the dorsal neural after 48
hours, but not 72 hours. Embryos electroporated with Pax3/GFP and Pax7/GFP reveal
that Pax3 (red) and Pax7 mis-expression downregulates Brn-3a (green) at both 48 and 72
hours after electroporations (D, I).
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Figure 24. Graph showing the averaged right:left ratios of Brn-3a+ cells in the WT
neural tube, and the averaged experimental:contralateral ratios of Brn-3a+ cells in
Cont/GFP, Pax3/GFP, Pax3/GFP + Pax7/GFP, and Pax7/GFP electroporated embryos
after 48 and 72 hours post-electroporation. The resulting Pax3/GFP, Pax3/GFP +
Pax7/GFP, and Pax7/GFP ratios were significantly different from WT and Cont/GFP
ratios (*P<0.01) after 48 hours post-electroporations. 72 hours after electroportions, only
Pax3/GFP + Pax7/GFP experimental embryos showed continued downregulation of Brn3a (**P<0.05). Paired t-test was used to generate statistical significance.
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Table 6. Summary of Brn-3a neural tube staining results
Brn-3a
24 hours
Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7

Total Number of
Embryos
Sectioned
3
5
5
7
7

Average neural
tube cell
counts
0.769
0.867

STDEV of
neural tube
cells counts
0.109
0.076

Total Number of
Embryos
Sectioned
4
4
5
5
4

Average neural
tube cell
counts
0.995
0.891
0.469
0.312
0.352

STDEV of
neural tube
cells counts
0.03
0.093
0.123
0.091
0.116

Total Number of
Embryos
Sectioned
3
4
4
4
4

Average neural
tube cell
counts
0.948
0.802
0.921
0.657
0.93

STDEV of
neural tube
cells counts
0.056
0.098
0.098
0.062
0.129

Brn-3a
48 hours
Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7
Brn-3a
72 hours
Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7
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Figure 25. Immunohistochemistry on transverse sections through the neural tube show
downregulation of Lhx1/5 in response to Pax3/GFP, Pax3/GFP + Pax7/GFP, and
Pax7/GFP electroporations after 48 and 72 hours. In all panels, left is the control side,
and right is the electroporated side of the embryo. (A, B, F, G) Immunofluorescence
staining of WT and Cont/GFP cross sections showing expression of Pax3 (red in A, F),
GFP (pseudocolored red in B, G), and Lhx1/5 (green) in the neural tube 48 and 72 hours
after electroporations. WT and Cont/GFP sections show equal levels of Lhx1/5
expression between left/right sides of neural tube at both time points. Immunofluorescent
staining of Pax3 (red in C, H), Pax7 (red in E, J), and Lhx1/5 (green) in embryos
electroporated with Pax3/GFP or Pax7/GFP reveal that Lhx1/5 positive cells are
downregulated in response to mis-expression of Pax3 or Pax7 in the dorsal neural after 48
hours, but not 72 hours. Embryos electroporated with Pax3/GFP and Pax7/GFP reveal
that Pax3 (red) and Pax7 mis-expression downregulates Lhx1/5 (green) at both 48 and 72
hours after electroporations (D, I).
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Figure 26. Graph showing the averaged right:left ratios of Lhx1/5+ cells in the WT
neural tube, and the averaged experimental:contralateral ratios of Lhx1/5+ cells in
Cont/GFP, Pax3/GFP, Pax3/GFP + Pax7/GFP, and Pax7/GFP electroporated embryos
after 48 and 72 hours post-electroporation. The resulting Pax3/GFP, Pax3/GFP +
Pax7/GFP, and Pax7/GFP ratios were significantly different from WT and Cont/GFP
ratios (*P<0.05) after 48 hours post-electroporations. 72 hours after electroportions, only
Pax3/GFP + Pax7/GFP experimental embryos showed continued downregulation of Brn3a (**P<0.05). Paired t-test was used to generate statistical significance.
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Table 7. Summary of Lhx1/5 neural tube staining results
Lhx1/5
24 hours
Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7

Total Number of
Embryos
Sectioned
3
5
5
7
7

Average neural
tube cell
counts
0.989
0.975
0.409
0.278
0.519

STDEV of
neural tube
cells counts
0.298
0.35
0.087
0.236
0.317

Total Number of
Embryos
Sectioned
4
4
5
5
4

Average neural
tube cell
counts
1.034
0.831
0.521
0.406
0.442

STDEV of
neural tube
cells counts
0.206
0.125
0.091
0.098
0.106

Total Number of
Embryos
Sectioned
3
4
4
4
4

Average neural
tube cell
counts
0.981
0.979
0.847
0.387
0.937

STDEV of
neural tube
cells counts
0.061
0.056
0.174
0.086
0.056

Lhx1/5
48 hours
Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7
Lhx1/5
72 hours
Gene
Analyzed
WT
GFP
Pax3
Pax3/7
Pax7
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varied from little to no detectable expression, and so the 24 hour electroporation time
point was therefore not included in the analysis for cell counts. WT embryos were used
to match endogenous expression levels of Brn-3a and Lhx1/5 at 48 and 72 hours after
electroporated stages (Brn-3a, Fig.23A, F; Lhx1/5, Fig.25A, F). Cont/GFP
electroporations revealed little or no visible change in Brn-3a or Lhx1/5 expression at 48
or 72 hours after electroporations (Brn-3a, Fig.23B, G; Lhx1/5, Fig.25B, G).
Electroporations with Pax3 and Pax7 however showed some differences. 48 hours after
electroporations with Pax3/GFP and Pax7/GFP individually and collectively, Brn-3a
(Pax3, Fig.23C; Pax3/7, Fig.23D; Pax7, Fig.23E) and Lhx1/5 (Pax3, Fig.25C; Pax3/7,
Fig.25D; Pax7, Fig.25E) were both downregulated in targeted neural tube tissue.
Interestingly, 72 hours after electroporations, Brn-3a (Pax3, Fig.23H; Pax3/7, Fig.23I;
Pax7, Fig.23J) and Lhx1/5 (Pax3, Fig.25H; Pax3/7, Fig.25I; Pax7, Fig.25J) expression
levels returned to normal in embryos electroporated with either Pax3/GFP or Pax7/GFP,
but not in embryos co-electroporated with Pax3/GFP and Pax7/GFP. Embryos
electroporated with Pax3/GFP and Pax7/GFP showed sustained downregulation of Brn3a (Fig.23I) and Lhx1/5 (Fig.25I) expression. It became apparent that overall expression
of Brn-3a and Lhx1/5 was downregulated wherever Pax3 and/or Pax7 were misexpressed 48 hours after electroporation. These results were somewhat puzzling since
neurofilament staining of commissural axons at 24-72 hour post-electroporation time
points showed no discernable reduction in commissural interneurons.
To quantitatively analyze the expression of Brn-3a and Lhx1/5 in response to
Pax3 and Pax7 mis-expression, cell counts were taken to compare left/right neural tube
(Brn-3a, Fig.24; Lhx1/5, Fig.26). WT averages for Brn-3a+ and Lhx1/5+ cells at 48
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hours (Brn-3a, 0.995 ± 0.030; Lhx1/5, 1.034 ± 0.206), and 72 hours (Brn-3a, 0.948 ±
0.052; Lhx1/5, 0.981 ± 0.061) showed relatively equal cell ratios between left/right
neural tube. Embryos electroporated with Cont/GFP were stained and analyzed,
revealing that the averages were not significantly different from WT neural tube cell
ratios for Brn-3a+ and Lhx1/5+ cells at 48 hours (Brn-3a, 0.891 ± 0.093; Lhx1/5, 0.831 ±
0.125), and 72 hours (Brn-3a, 0.802 ± 0.098; Lhx1/5, 0.979 ± 0.056) after
electroporations (p>0.14 for all comparisons). In embryos electroporated with
Pax3/GFP, the neural tube cell count ratios for Brn-3a+ and Lhx1/5+ cells at 48 hours
(Brn-3a, 0.469 ± 0.123; Lhx1/5, 0.521 ± 0.091), were significantly different from the
control Cont/GFP and WT results (p<0.001 for both). However, Brn-3a+ and Lhx1/5+
cell counts after 72 hours were not significantly different from Cont/GFP or WT
(p>0.199). Pax7/GFP mis-expression generated relatively the same significance as
Pax3/GFP mis-expression. Cell count ratios for Brn-3a+ and Lhx1/5+ cells at 48 hours
(Brn-3a, 0.352 ± 0.116; Lhx1/5, 0.442 ± 0.106), were significantly different from the
control Cont/GFP and WT results (p<0.001 for both). 72 hours after electroporations,
Brn-3a+ and Lhx1/5+ cell counts were not significantly different from Cont/GFP or WT
(p>0.373). However, embryos electroporated with both Pax3/GFP and Pax7/GFP
showed a significant reduction in Brn-3a+ and Lhx1/5+ cells at 48 hours (Brn-3a, 0.312
± 0.091; Lhx1/5, 0.406 ± 0.098), and 72 hours (Brn-3a, 0.657 ± 0.073; Lhx1/5, 0.387 ±
0.086) when compared with controls (p<0.001 for 48 hours, p<0.05 for 72 hours). The
combined effects of Pax3 and Pax7 appeared have a greater effect on sustained Brn-3a
and Lhx1/5 expression than either gene electroporated alone.
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Discussion
The cell-autonomous functions of Pax3 and Pax7 in the development of dorsal
interneurons have not been well studied, even though previous research shows the
relative expression patterns of Pax3 and Pax7 domains and their ability to restrict dorsal
ventral identity. It has also been shown in knockout experiments that these genes are
required for proper development of commissural interneurons (Mansouri and Gruss,
1998). Other factors such as BMP and Shh signaling that establish the DV identity of the
neural tube make it difficult to determine the cell-autonomous function of the genes that
are regulated within these distinct boundaries. Because of such factors, it is difficult to
determine if Pax3 or Pax7 are functioning independent of BMP signaling and other genes
expressed in the dorsal neural tube. Pax3 and Pax7 are known to have redundant
functions in the neural tube (Mansouri et al., 1998), and so experiments designed to
understand the function of either gene can be difficult. In this study we used tissue
specific targeting with Pax3 and Pax7 mis-expression constructs to analyze the effects of
these genes on neuronal differentiation within the neural tube.

Pax3 and Pax7 are sufficient to stop motoneuron differentiation in the ventral neural
tube, independent of BMP signaling
Because previous research shows that ectopic expression of BMP can induce
Pax3 expression in the basal floor plate, resulting in an absence of motorneuron
differentiation (Monsoro-Burq et al., 1996; Liem et al., 1997), we aimed to distinguish
between the dorsalizing effects of BMP and Pax3 in the basal floor plate. To accomplish
this we electroported Pax3/GFP and Pax7/GFP into the ventral neural tube and observed
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motorneuron differentiation. Our results showed that mis-expression of Pax3 and Pax7
individually and collectively prevents normal motorneuron differentiation as assayed by
Islet1 expression. This was necessary to determine if the dorsalizing effects of BMP was
due to Pax3 expression alone, or a combination of other factors initiated by BMP
signaling. Continued mis-expression of Pax3 and Pax7 revealed that relative levels of
Islet1 protein remained downregulated from 24-72 hours after electroporations. Since
Islet1 is a marker for motorneuron differentiation in the neural tube, this data suggests
that maintained expression of Pax3 and/or Pax7 in these cells may stop these cells from
differentiating into motorneurons. It is interesting to note that either transcription factor
was capable of downregulating Islet1, suggesting that they can share a similar function in
restricting ventral neuron identity.

Mis-expression of Pax3 and Pax7 causes downregulation of dorsal interneuron
progenitors and is not sufficient to cause ectopic expression of commissural neurons
Qualitative analysis of axons generated by the commissural neurons indicated that
mis-expression of Pax3 and Pax7 in the ventricular zone did not affect overall
development of these interneurons. Since neurofilament staining marked other neurons
in addition to commissural axons, we devised a different approach to analyze cellautonomous expression of commissural neurons. Markers for dorsal interneuron
progenitors were used to count individual cells and compare electroporated and nonelectorporated neural tube. Even though we did not observe any changes in commissural
neuron expression through neurofilament staining, mis-expression of Pax3 and Pax7 did
affect interneuron differentiation as indicated by the expression of the transcription
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factors Brn-3a and Lhx1/5, both of which are expressed in commissural neurons (Helms
and Johnson 2003). Interestingly, mis-expression of Pax3 and Pax7 individually only
transiently downregulated Brn-3a and Lhx1/5, as these endogenous expression levels
returned to normal 72 hours after electroporations. However, mis-expression of both
Pax3 and Pax7 together caused Brn-3a and Lhx1/5 to remain downregulated, even 72
hours after electroporations. This additive effect may account for why expression of both
genes in the dorsal neural tube is necessary for restriction and patterning of the neural
tube, though they share some redundant function.
Staining of WT embryos for Pax3, Pax7, and other neuronal differentiation
markers reveal that as the embryos develop and the cells within the neural tube divide
and differentiation into interneurons and motorneurons, that Pax3 and Pax7 expression
may be downregulated in cells migrating from the ventricular zone into the outer mantle
zone, where they then begin to express markers of interneuron differentiation. Even
though Pax3 and Pax7 share a redundant function in the neural tube, it is possible that the
combined effects of both of these genes are necessary to maintain the boundary between
the mantle zone and the ventricular zone of the neural tube. Previous research indicates
that in the absence of both genes, neural cell fate is affected such that some cells located
dorsally acquire ventral interneuron identity (Mansouri and Gruss, 1998). Interneuron
progenitor cells express certain transcription factors depending on their location in the
neural tube. These dorsal interneurons are derived from progenitors in the ventricular
zone. Neuronal induction of these progenitor cells depends on cell cycle exit,
translocation of the cells laterally out of the ventricular zone, and expression of these
neuronal markers. Their spatial expression is in non-overlapping patterns in these
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progenitor cells along the dorsoventral axis. It is possible that though initial expression
of Pax3 and Pax7 may be necessary for early stages of neuronal development, that
continued neuronal differentiation of these interneurons depends on their ability to
translocate to the mantle zone and downregulate Pax3 and Pax7. This is supported by our
data in that continued exposure to Pax3 and Pax7 in the mantle zone causes
downregulation of these markers.
Though Pax3 and Pax7 are necessary to restrict ventral neuron identity, our data
suggests that downregulation of both genes is necessary for continued differentiation of
interneurons migrating from the ventricular zone to the mantle zone. Previous research
suggests that context-dependent protein-protein interactions are important for the distinct
function of each neural factor in the development of these interneurons (Nakada et al.,
2004). It is also possible that the context-dependent protein-protein interactions between
cells expressing Pax3 and Pax7 and those not, are necessary for proper neuronal
differentiation. Since the neuroepithelial cells within the ventricular zone that divide
vertically instead of horizontally usually remain stem cells, it is possible that continued
Pax3 and Pax7 expression within these cells is necessary to maintain an undifferentiated
state. Previous research suggests that bHLH factors Math1, Ngn1, and Mash1 are
required for cell-cycle exit and induction of neuronal differentiation of these progenitor
cells (Cai et al., 2000; Fara et al., 2000; Sun et al., 2001). It is obvious that Pax3 and
Pax7 individually or collectively are not the only factors involved in neuronal
differentiation of dorsal interneurons. Mis-expression of Pax3 and Pax7 in the ventral
neural tube may stop motorneuron differentiation. Dorsal interneuron differentiation,
indicated by Brn-3a and Lhx1/5 expression, are not ectopically expressed and therefore
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may need addition factors for proper neuronal differentiation. Further analysis of the
effect of Pax3 and Pax7 on the genes required for cell-cycle exit and induction of neural
differentiation may give us a greater understanding the exact role that Pax3 and Pax7 play
in the specification of dorsal interneurons.
In conclusion, we hypothesize that restriction of Pax3 and Pax7 to the ventricular
zone of the developing neural tube is a necessary step for continued differentiation of
dorsal interneurons. While Pax3 and Pax7 may be necessary for initial restriction of the
dorsal neural tube, the establishment of dorsal identity, and commissural neuron
differentiation, continued expression of these genes in progenitor cells during
development will stop interneuron differentiation.
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